Biomarkers predict development breast cancer

06-06-2019

In order to further improve the personalized treatment of breast cancer patients scientists are continuously searching for patient and tumor characteristics that could predict how patients will fare and which treatment will work best.

Marcelo Sobral-Leite studied several of such biomarker during his PhD research. He discovered that the protein Annexin A1 can be valuable for predicting the breast cancer survival of patients in high risk groups, such as patients with HER2-positive cancers. He also investigated the predictive value of immune cells present in the tumor. He will defend his thesis at Utrecht University on June 11^th. Good luck Marcelo!

Practical information about the defense can be found on UMC Utrecht's website.

Biomarkers predict development breast cancer

This site uses cookies